Literature DB >> 10914337

Hazardous materials readiness of United States level 1 trauma centers.

D P Ghilarducci1, R G Pirrallo, K T Hegmann.   

Abstract

Injuries caused by hazardous materials (hazmat) accidents are common in the United States, and emergency departments should be capable of decontaminating these patients. There are, however, no national studies that assess emergency department preparedness. The purpose of this survey was to assess the hazmat readiness of US Level 1 trauma centers (TCs). All 1996 Hospital Blue Book TCs (256) were queried by anonymous survey; 61% (156) responded to the survey. The TCs treated 43,046 +/- 28,455 patients (median, 40,500; range, 600 to 220,000); 15 +/- 29 (median, 6; range, 0 to 200) were hazmat-contaminated. Only 6% acknowledged having all necessary equipment required for safe decontamination. Many (83%) had hazmat response plans, but few (30%) of these plans were complete. Approximately 36% of the staff had received training. Thirteen staff required medical attention themselves after rendering care to a contaminated patient. Only 58% of the TCs performed a single drill. The preparedness of US Level 1 TCs to safely decontaminate hazmat patients seems to be inadequate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914337     DOI: 10.1097/00043764-200007000-00002

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

1.  Threat of Secondary Chemical Contamination of Emergency Departments and Personnel: An Uncommon but Recurrent Problem.

Authors:  Theodore C Larson; Maureen F Orr; Erik Auf der Heide; Jennifer Wu; Sutapa Mukhopadhyay; D Kevin Horton
Journal:  Disaster Med Public Health Prep       Date:  2015-11-10       Impact factor: 1.385

Review 2.  Clinical review: Tokyo - protecting the health care worker during a chemical mass casualty event: an important issue of continuing relevance.

Authors:  Sumie Okumura; Tetsu Okumura; Shinichi Ishimatsu; Kunihisa Miura; Hiroshi Maekawa; Toshio Naito
Journal:  Crit Care       Date:  2005-02-17       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.